natgillin/translations-raw huggingface dataset:
It must also ensure that all doctors who intend to prescribe Gilenya receive an information pack containing important safety information, including a checklist of the risks with Gilenya and the situations where its use is not recommended.
Zagotoviti mora tudi, da bodo vsi zdravniki, za katere se pričakuje, da bodo predpisovali zdravilo Gilenya, prejeli informativno gradivo, ki bo vsebovalo pomembne varnostne informacije, vključno s seznamom tveganj, povezanih z zdravilom Gilenya, in primeri, pri katerih njegova uporaba ni priporočena.
It must also not be given to animals that are hypersensitive to telmisartan or any of the other ingredients of the product.
Ne sme se dajati živalim, ki so preobčutljive za telmisartan ali katero koli drugo sestavino zdravila.
It must also not be given to patients who have disorders that cause severe abnormalities of the immune system called ‘severe combined immunodeficiency’, who have had intussusception in the past, or who have problems with their bowel that could put them at risk of intussusception.
Ne sme se uporabljati pri bolnikih z obolenji, ki povzročajo resne nepravilnosti imunskega sistema, imenovane „huda kombinirana imunodeficienca“, ki so v preteklosti imeli invaginacijo ali ki imajo težave s črevesjem, zaradi česar obstaja nevarnost za invaginacijo.
It must also not be given to patients with certain blood or immune diseases.
Ne sme se uporabiti pri bolnikih z določenimi krvnimi ali imunskimi boleznimi.
It must also not be used by patients who have severely reduced liver or kidney function, or who have had loss of vision because of a problem with blood flow to the nerve in the eye (non-arteritic anterior ischaemic optic neuropathy, NAION) that can be triggered by this class of medicines.
Prav tako ga ne smejo uporabljati bolniki z močno okrnjenim delovanjem jeter ali ledvic ali bolniki, ki so izgubili vid zaradi težav z dotokom krvi v očesni živec (nearteritična anteriorna ishemična optična nevropatija – NAION), ki jih lahko sproži ta skupina zdravil.
It must also not be used in certain cases where the back part of the membrane that surrounds the lens (the lens capsule) has been ruptured.
Prav tako se ne sme uporabljati v primerih, kadar je poškodovan zadnji del membrane, ki obdaja lečo (lečna kapsula).
It must also not be used in dogs with severely impaired liver, kidney or heart function.
Prav tako se ne sme uporabljati pri psih s hudo okvaro jeter, ledvic ali srca.
It must also not be used in patients about to undergo major orthopaedic surgery who have severe cardiovascular (heart and blood vessel) problems including a recent heart attack or stroke.
Prav tako se ne sme uporabljati pri bolnikih, ki so tik pred zahtevnejšim ortopedskim kirurškim posegom in imajo resne kardiovaskularne (srčno-žilne) težave, vključno z nedavnim srčnim napadom ali možgansko kapjo.
It must also not be used in patients who are suspected to have had in the past an allergic reaction called ‘allergic contact dermatitis’ to Exelon patch.
Prav tako ga ne smejo ga uporabljati bolniki, pri katerih obstaja sum, da so v preteklosti doživeli alergijsko reakcijo, imenovano „alergijski kontaktni dermatitis“, na obliže zdravila Exelon.
It must also not be used in patients who are suspected to have had in the past an allergic reaction called ‘allergic contact dermatitis’ to Exelon patch.
Prav tako ga ne smejo uporabljati bolniki, pri katerih obstaja sum, da so v preteklosti doživeli hudo alergijsko reakcijo, imenovano „alergijski kontaktni dermatitis“, na obliže zdravila Exelon.
It must also not be used in patients who are taking any of the following medicines, which could cause harmful side effects if taken with Invirase: medicines that could cause QT prolongation or PR prolongation (another type of heart activity alteration);
Prav tako se ne sme uporabljati pri bolnikih, ki jemljejo katero od naslednjih zdravil, ki bi lahko povzročila škodljive neželene učinke, če se vzamejo skupaj z zdravilom Invirase: zdravila, ki bi lahko povzročila podaljšanje intervala QT ali PR (drugi vrsti spremembe delovanja srca);
It must also not be used in patients who are taking certain other medicines that affect the way Deltyba is broken down in the body.
Prav tako se ne sme uporabljati pri bolnikih, ki jemljejo nekatera druga zdravila, ki vplivajo na način njegove razgradnje v telesu.
It must also not be used in patients who are taking medicines that slow down the breakdown of Valdoxan in the body, such as fluvoxamine (another antidepressant) and ciprofloxacin (an antibiotic).
Prav tako ga ne smejo uporabljati bolniki, ki jemljejo zdravila, ki upočasnjujejo presnovo zdravila Valdoxan v telesu, kot sta fluvoksamin (drug antidepresiv) in ciprofloksacin (antibiotik).
It must also not be used in patients who have ever had loss of vision because of a problem with blood flow to the nerve in the eye (non-arteritic anterior ischemic optic neuropathy or NAION).
Prav tako ga ne smejo jemati bolniki, ki so kadar koli imeli težave z vidom zaradi dotoka krvi v očesni živec (nearteritična anteriorna ishemična optična nevropatija – NAION).
It must also not be used in patients who have had a stroke within the last 3 months.
Uporabljati se ne sme niti pri bolnikih, ki so v zadnjih treh mesecih doživeli možgansko kap.
It must also not be used in patients who have had facial radiotherapy (treatment with radiation) or who have recurrent episodes of epistaxis (nosebleeds).
Prav tako ga ne smejo uporabljati bolniki, ki so pred tem imeli radioterapijo (zdravljenje z obsevanjem) v predelu obraza, ali bolniki s ponavljajočimi se epizodami krvavitev iz nosu.
It must also not be used in patients who have received a bone marrow transplant from a donor, or who are taking steroids (medicines used to reduce or prevent inflammation) given systemically (given as treatment throughout the body), clonidine (used to reduce high blood pressure) or histamine H2 blockers (used to treat stomach ulcers, indigestion or heartburn).
Zdravila prav tako ne smejo uporabljati bolniki, ki so jim presadili kostni mozeg tujega darovalca ali jemljejo steroide (zdravila za zmanjšanje ali preprečevanje vnetja) kot sistemska zdravila (zdravila, ki delujejo na vse telo), klonidin (zdravilo za zmanjšanje visokega krvnega tlaka) ali zaviralce histamina H2 (zdravila za zdravljenje želodčnih razjed, prebavnih motenj ali zgage).
It must also not be used in patients with advanced heart block (a type of heart rhythm disorder), patients with uncontrolled hypotension and in patients with conditions such as stroke that affect the blood supply to the brain.
Prav tako ga ne smejo uporabljati bolniki z napredovalim srčnim blokom (motnjo srčnega ritma), bolniki z nenadzorovano hipotenzijo in bolniki z boleznimi, kot je kap, ki prizadenejo oskrbo možganov s krvjo.
It must also not be used in patients with alcohol intoxication (excessive alcohol consumption) or alcoholism, or during breast- feeding.
Prav tako se ne sme uporabljati pri bolnikih z akutno zastrupitvijo z alkoholom (prekomerno uživanje alkohola) ali v primeru alkoholizma oziroma med dojenjem.
It must also not be used in patients with intestinal perforation or obstruction, severe inflammatory conditions of the intestines such as Crohn’s disease, ulcerative colitis (inflammation of the large intestine causing ulceration and bleeding) and toxic megacolon and megarectum (very serious complications of colitis).
Ne sme se uporabljati niti pri bolnikih s perforacijo ali zaporo črevesja, hudimi vnetnimi stanji črevesja, kot je Crohnova bolezen, ulcerativnim kolitisom (vnetjem debelega črevesja, ki povzroči razjede in krvavitve) in toksičnim megakolonom in megarektumom (zelo hudim zapletom kolitisa).
It must also not be used in patients with life-threatening allergy to eggs or any of Kanuma’s ingredients.
Prav tako se ga ne sme uporabljati pri bolnikih s smrtno nevarno alergijo na jajca ali katero koli sestavino zdravila Kanuma.
It must also not be used in patients with severe reduction in liver function or high levels of liver enzymes in the blood.
Zdravilo se prav tako ne sme uporabljati pri bolnikih, ki imajo hudo okvaro delovanja jeter ali visoke ravni jetrnih encimov v krvi.
It must also not be used in patients with severely reduced liver function.
Ne sme se uporabljati pri bolnikih s hudo okvaro delovanja jeter.
It must also not be used in patients with some other heart problems, such as some problems with the electrical activity, very slow heart beats or heart failure.
Prav tako ga ne smejo uporabljati bolniki z nekaterimi drugimi srčnimi težavami, kot so težave z električno aktivnostjo, zelo počasno bitje srca ali srčno popuščanje.
It must also not be used in people who are known to have allergic reactions to mouse or hamster protein.
Ne sme se uporabljati pri ljudeh, za katere je znano, da imajo alergijsko reakcijo na mišje ali hrčkove beljakovine.
It must also not be used in the following groups: patients currently receiving another fluoropyrimidine (a group of anticancer medicines that includes Teysuno) or who have had severe and unexpected reactions to fluoropyrimidines; patients with a deficiency of the enzyme dihydropyrimidine dehydrogenase (DPD) as well as patients who, within the previous four weeks, have been treated with a medicine that inhibits this enzyme;
Prav tako ga ne smejo uporabljati naslednje skupine bolnikov: bolniki, ki trenutno prejemajo drugi fluoropirimidin (skupino zdravil proti raku, v kateri je tudi zdravilo Teysuno) ali ki so imeli hude in nepričakovane reakcije na fluoropirimidine; bolniki s pomanjkanjem encima dihidropirimidin dehidrogenaza (DPD) ter bolniki, ki so bili pretekle štiri tedne zdravljeni z zdravilom, ki zavira ta encim;
It must also not be used in women who are more than three months pregnant or in patients taking medicines containing ciclosporin, itraconazole or other medicines known as ‘potent P- glycoprotein inhibitors’ (such as quinidine).
Prav tako ga ne smejo uporabljati ženske, ki so noseče več kot tri mesece, ali bolniki, ki jemljejo zdravila, ki vsebujejo ciklosporin in itrakonazol, ali druga zdravila, znana kot močni zaviralci P-glikoproteina (kot je kinidin).
It must also not be used in women who could become pregnant, unless they take all of the necessary steps to ensure that they are not pregnant before treatment and that they do not become pregnant during or soon after treatment.
Prav tako ga ne smejo uporabljati ženske, ki bi utegnile zanositi, razen če ne ukrenejo vsega potrebnega, da zagotovijo, da pred začetkom zdravljenja niso noseče, in da ne zanosijo med zdravljenjem ali neposredno po koncu tega.
It must also not be used in women who have malformations of the sexual organs or fibroid tumours of the womb that would stop them from becoming pregnant.
Ne sme se uporabljati pri ženskah, ki imajo nepravilno oblikovane spolne organe ali fibroidne tumorje maternice, zaradi katerih ne morejo zanositi.
It must also not be used in women with abnormal (not menstrual) bleeding from the vagina without a known cause, primary ovarian failure, enlarged ovaries or ovaries with cysts, polycystic ovarian syndrome or in women with a history of OHSS.
Ne smejo ga uporabljati niti ženske z nenormalno (nemenstrualno) krvavitvijo iz nožnice brez znanega vzroka, primarno odpovedjo jajčnikov, povečanimi jajčniki, jajčniki s cistami ali sindromom policističnih jajčnikov in ženske, ki so imele v preteklosti sindrom OHSS.
It must also not be used to treat severe bleeding from the arteries.
Prav tako se ne sme uporabljati za zdravljenje hudih arterijskih krvavitev.
It must also not be used together with medicines called ‘PDE 5 inhibitors’ (a class of medicines used for PAH or erectile dysfunction) or with nitrates or nitric oxide donors (often used to treat high blood pressure, chest pain and heart disease, or as recreational drugs).
Prav tako se ne sme uporabljati skupaj z zdravili, ki jih imenujemo „zaviralci PDE5“ (skupina zdravil, ki se uporabljajo za PAH ali erektilno disfunkcijo), in z nitrati ali donorji dušikovega oksida (ti se pogosto uporabljajo za zdravljenje visokega krvnega tlaka, bolečin v prsnem košu in bolezni srca ali kot rekreacijske droge).
It must also not be used together with medicines that affect the activity of certain enzymes that can raise or lower the level of the active substance in the blood.
Prav tako se ne sme uporabljati skupaj z zdravili, ki vplivajo na delovanje določenih encimov, ki lahko zvišajo ali znižajo raven zadevne zdravilne učinkovine v krvi.
It must also not be used together with medicines that affect the activity of certain enzymes that can raise or lower the levels of its active substances in the blood.
Prav tako se ne sme uporabljati skupaj z zdravili, ki vplivajo na delovanje določenih encimov, ki lahko zvišajo ali znižajo ravni zadevnih zdravilnih učinkovin v krvi.
It must also not be used together with the following medicines known as potent P-gp inducers as these can reduce the effects of Harvoni :
Prav tako se ne sme uporabljati skupaj z naslednjimi zdravili, znanimi kot močnimi induktorji P-gp, saj lahko zmanjšajo učinke zdravila Harvoni:
It must also not be used with the herbal remedy St. John’s wort (used for depression and anxiety), or the epilepsy medicines carbamazepine and phenytoin because these medicines may affect the way Zepatier works.
Prav tako se ne sme uporabljati skupaj s šentjanževko, zdravilom rastlinskega izvora (ki se uporablja pri depresiji in tesnobnosti), ali s karbamazepinom in fenitoinom, zdraviloma za zdravljenje epilepsije, ker lahko ta zdravila vplivajo na način delovanja zdravila Zepatier.
It must be a clear, colourless or slightly pearly liquid.
Tekočina mora biti bistra, brezbarvna ali rahlo biserna.
It must be a clear, colourless to slightly yellow solution.
Biti mora bistra, brezbarvna do rumenkasta raztopina.
It must be clear to opalescent, without particles and without any visible signs of deterioration.
Biti mora bister do opalescenten, brez delcev in vidnih znakov kvarjenja.
It must be clear to slightly opalescent (slightly unclear).
Biti mora bistra do rahlo opalescentna (rahlo motna).
It must be clear, have no colour and no solid pieces in it.
Biti mora bistero in brezbarvno in ne sme vsebovati trdnih delcev.
It must be ensured that the Final Product Disposition Notification form containing the patient identifiers, expiration date and time, and the disposition status (approved for infusion or rejected), has been received from the market authorisation holder.
Zagotoviti je treba, da ste od imetnika dovoljenja za promet z zdravilom prejeli obrazec z obvestilom o končnem razpolaganju z zdravilom, ki vsebuje podatke za bolnikovo identifikacijo, datum in čas poteka roka uporabnosti in stanje razpolaganja (odobreno za infundiranje ali zavrnjeno).
It must be ensured that the Final Product Disposition Notification form containing the patient identifiers, expiration date and time, and the disposition status (approved for infusion or rejected), has been received from the marketing authorisation holder.
Zagotoviti je treba, da ste od imetnika dovoljenja za promet z zdravilom prejeli obrazec z obvestilom o končnem razpolaganju z zdravilom, ki vsebuje podatke za bolnikovo identifikacijo, datum in čas poteka roka uporabnosti in stanje razpolaganja (odobreno za infundiranje ali zavrnjeno).
It must be ensured that the patient’s identity matches the essential unique patient information on the Provenge bag and on the Final Product Disposition form.
Zagotoviti je treba, da se identiteta bolnika ujema z bistveno edinstveno informacijo o bolniku na vrečki z zdravilom Provenge in na obrazcu z obvestilom o končnem razpolaganju z zdravilom.
It must be ensured that the patient’s identity matches the essential unique patient information on the Provenge bag and the Final Product Disposition Notification form.
Zagotoviti je treba, da se identiteta bolnika ujema z bistveno edinstveno informacijo o bolniku na vrečki z zdravilom Provenge in na obrazcu z obvestilom o končnem razpolaganju z zdravilom.
It must be given with other medicines that also prevent nausea and vomiting, including a corticosteroid (such as dexamethasone) and a ‘5-HT3 antagonist’ (such as ondansetron).
Zdravilo je treba jemati z drugimi zdravili za preprečevanje slabosti in bruhanja, vključno s kortikosteroidi (kot je deksametazon) in antagonisti ‘5- HT3 (kot je ondansetron).
It must be remembered that insulin protamine crystals dissolve in an acid pH range, the soluble insulin part precipitates out at a pH of approximately 4.5 to 6.5.
Zavedati se je treba, da: se kristali insulin protamina raztapljajo v kislem pH območju, topni del insulina precipitira v območju pH približno od 4,5 do 6,5.
It must be returned to the refrigerator for storage longer than 24 hours.
Za shranjevanje, daljše od 24 ur, ga je treba dati nazaj v hladilnik.
It must be used with an approved type of sponge made of gelatin.
Uporabljati ga je treba skupaj z odobreno vrsto želatinske gobice.
It must not be administered as an intravenous push or bolus.
Ne sme se ga dajati kot hitro intravensko infuzijo ali bolus.
It must not be administered if the following conditions occur: infections requiring administration of ganciclovir (GCV) or valganciclovir (VCV) at the time of infusion;
Zdravila ni dovoljeno dajati, če se pojavijo naslednja stanja: okužba, zaradi katere je treba dajati ganciklovir (GCV) ali valganciklovir (VCV) v času infundiranja;
It must not be given at the same time as the following medicines:
Ne sme se uporabljati sočasno z naslednjimi zdravili:
It must not be given in combination with other disease-modifying medicines, to patients who have cancer (unless it is a type of skin cancer called basal cell carcinoma) or to patients who are under 18 years of age.
Ne sme se ga dajati v kombinaciji z drugimi zdravili za spreminjanje poteka bolezni, bolnikom, ki imajo raka (razen če gre za kožni rak, imenovan bazocelularni karcinom kože), ali mlajšim od 18 let.
It must not be given into a muscle or under the skin, or as a ‘bolus’ injection (all at once).
Ne sme se dajati v mišico ali v podkožje oziroma v obliki bolusne injekcije (celotna vsebina na enkrat).
It must not be injected into a blood vessel such as a vein or an artery.
Ne sme se injicirati v krvno žilo, kot je na primer vena ali arterija.
It must not be shared with anyone else.
Ne delite ga z nikomer drugim.
It must not be shared with anyone else.
Ne sme ga deliti z nikomer drugim.
It must not be taken with ciclosporin, itraconazole or other medicines known as ‘potent P-glycoprotein inhibitors’ (such as quinidine).
Ne sme se jemati skupaj s ciklosporinom, itrakonazolom ali drugimi zdravili, za katere je znano, da so močni zaviralci P-glikoproteina (kot je kinidin).
It must not be taken with ciclosporin, itraconazole or other medicines known as ‘potent P-glycoprotein inhibitors’ (such as quinidine).
Ne sme se jemati skupaj s ciklosporinom, itrakonazolom ali drugimi zdravili, znanimi kot „močni zaviralci P- glikoproteina“ (kot je kinidin).
It must not be taken with ciclosporin, itraconazole, or other medicines known as ‘potent P-glycoprotein inhibitors’ (such as quinidine).
Ne sme se jemati skupaj s ciklosporinom, itrakonazolom ali drugimi zdravili, znanimi kot „močni zaviralci P- glikoproteina“ (kot je kinidin).
It must not be used if it remains clear or if, for example, clumps, flakes, particles or anything similar are in the suspension or on the sides or bottom of the cartridge in the pen.
Če ostane bistra ali so v njej ali pa ob straneh oz. na dnu vložka v injekcijskem peresniku npr. grude, kosmi, delci ali kaj podobnega, je ne smete uporabiti.
It must not be used if it remains clear or if, for example, clumps, flakes, particles or anything similar are in the suspension or on the sides or bottom of the cartridge.
Če ostane bistra ali so v njej ali pa ob straneh oz. na dnu vložka npr. grude, kosmi, delci ali kaj podobnega, je ne smete uporabiti.
It must not be used if there is any change in the appearance of the solution.
Raztopine ne uporabite, če opazite spremembe v njenem videzu.
It must not be used in cats weighing less than 2 kg.
Ne sme se uporabljati pri mačkah, ki tehtajo manj kot 2 kg.
It must not be used in dogs which are known to be hypersensitive (allergic) to indoxacarb, permethrin or to any of the other ingredients.
Ne sme se uporabljati pri psih, za katere je znano, da so preobčutljivi za (alergični na) indoksakarb, permetrin ali katero drugo sestavino zdravila.
It must not be used in dogs with problems affecting the stomach or gut, including ulcers or bleeding, or in dogs that have signs of bleeding problems.
Ne sme se uporabljati pri psih z motnjami v delovanju želodca ali črevesja, vključno z ulkusi in krvavitvami, ali pri psih, pri katerih se pojavljajo težave s krvavitvami.
It must not be used in infants who have had an allergic reaction after receiving a vaccine containing diphtheria, tetanus, pertussis, hepatitis B, polio or Hib in the past.
Ne sme se uporabljati pri otrocih, ki so imeli alergijsko reakcijo po prejšnjem cepivu, ki je vsebovalo davico, tetanus, oslovski kašelj, hepatitis B, polio ali Hib.
It must not be used in patients about to undergo major orthopaedic surgery who have severe cardiovascular (heart and blood vessel) problems including a recent heart attack or stroke.
Ne sme se uporabljati pri bolnikih, ki so tik pred zahtevnejšim ortopedskim kirurškim posegom in imajo resne kardiovaskularne (srčno-žilne) težave, vključno z nedavnim srčnim napadom ali možgansko kapjo.
It must not be used in patients in whom any previous HIV treatment combinations have failed to work or have stopped working.
Ne sme se uporabljati pri bolnikih, pri katerih katera koli prejšnja kombinacija zdravil proti virusu HIV ni bila uspešna ali je prenehala učinkovati.
It must not be used in patients taking any other anticoagulant medicine, except in specific situations such as when the anticoagulant medication is being switched.
Ne sme se uporabljati pri bolnikih, ki jemljejo kateri koli drugi antikoagulant, razen v posebnih primerih, kot je denimo prehod z enega antikoagulanta na drugega.
It must not be used in patients who are bleeding or in patients who have a liver disease or a condition that is associated with an increased risk of bleeding.
Ne sme se uporabljati pri bolnikih, ki krvavijo, ali bolnikih z jetrnim obolenjem ali stanjem, ki je povezano s povečanim tveganjem za krvavitve.
It must not be used in patients who are severely allergic to other ‘beta-lactam’ antibiotics, such as penicillins or cephalosporins.
Ne smejo ga uporabljati bolniki s hudimi alergijami na beta-laktam antibiotike, kot so na primer penicilini ali cefalosporini.
It must not be used in patients who get asthma attacks, urticaria (itchy rash) or acute rhinitis (stuffy and runny nose) from taking acetylsalicylic acid (aspirin) or other NSAIDs.
Ne smejo ga uporabljati bolniki, pri katerih acetilsalicilna kislina (aspirin) ali druga nesteroidna protivnetna zdravila sprožajo napade astme, urtikarijo (srbeč izpuščaj) ali akutni rinitis (zamašen nas in izcedek iz nosu).
It must not be used in patients who have developed pure red cell aplasia (reduced or stopped red blood cell production) following treatment with any erythropoietin, patients with hypertension (high blood pressure) that is not controlled, patients about to undergo surgery who have severe cardiovascular (heart and blood vessel) problems including a recent heart attack or stroke, or patients who cannot receive medicines to prevent blood clots.
Ne sme se uporabljati pri bolnikih, pri katerih se je pojavila čista aplazija rdečih krvnih celic (zmanjšanje ali ustavitev nastajanja rdečih krvnih celic) po zdravljenju s katerim koli eritropoetinom, bolnikih s hipertenzijo (visokim krvnim tlakom), ki ni nadzorovana, bolnikih pred operacijo, ki imajo hude kardiovaskularne težave (težave s srcem in ožiljem), vključno z nedavnim srčnim napadom ali kapjo, ali pri bolnikih, ki ne smejo jemati zdravil za preprečevanje nastajanja krvnih strdkov.